Jingna Fu

Jingna Fu is an accomplished professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Associate Director at AstraZeneca since July 2022, Jingna Fu focuses on ADC and TDE/TDR projects within Portfolio Strategy & Operations at Computational Pathology Munich in Early Oncology R&D. Previously, Jingna Fu held the positions of Program Manager at AstraZeneca and Senior Clinical Operational Specialist at MorphoSys, where key contributions included participation in the global Phase III clinical study MANIFEST-2 for Pelabresib and involvement in the tafasitamab global program. Jingna Fu's career began at the Huawei European Research Institute in a team assistant role, following an internship and assistant position at Pengda Munich GmbH. Educational qualifications include a Master of Science in Plant Genetics from the Technical University of Munich and ongoing studies at ESMT Berlin.